Skip to main content

Health condition

Paraneoplastic syndromes, the early warning your body can give before cancer is found.

Rare immune reactions to cancer that attack healthy nerves and muscle - sometimes appearing long before the underlying tumour is diagnosed. Recognising the pattern matters.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against NICE, Association of British Neurologists and peer-reviewed sources you can see at the end.

  • 03

    Current for 2026

    Reflects modern UK guidance on antibody testing, cancer screening pathways and specialist neuro-oncology care.

Key facts

Paraneoplastic syndromes at a glance.

The essentials, in plain English - what these disorders are, why they matter, and how they're found and treated in the UK today.

  • What it is

    A group of rare disorders caused by the immune system attacking cancer cells and, by mistake, healthy tissue too - often nerves, muscles or the brain.

  • The warning sign

    Symptoms can appear months or even years before a cancer is found - recognising the pattern can lead to an earlier cancer diagnosis.

  • Cancers involved

    Most often small cell lung cancer, ovarian cancer, thymoma, breast cancer and lymphoma - though many cancers can trigger a syndrome.

  • How it presents

    Varies widely - unsteady walking, memory changes, seizures, muscle weakness, or unusual eye and limb movements, depending on the syndrome.

  • How it is found

    Specific antibody blood tests (anti-Hu, anti-Yo, anti-Ri and others) alongside thorough cancer screening, even when no tumour is yet visible.

  • How it is treated

    Treating the underlying cancer first, plus immunosuppression for the autoimmune attack and symptom-specific medicines.

Why this guide matters

A symptom pattern that can find cancer early.

Paraneoplastic syndromes are rare, but recognising them promptly genuinely changes outcomes. The three points below shape everything else on this page.

  • Symptoms can come first

    Neurological symptoms often appear before a cancer is detectable on scans - noticing the pattern can lead to a much earlier cancer diagnosis.

  • The syndrome is not the tumour

    Damage comes from the immune system misfiring, not from the cancer spreading directly - which is why immunotherapy has a real role alongside cancer treatment.

  • Speed matters for recovery

    Starting treatment early, both for the cancer and the immune reaction, gives the best chance of limiting permanent neurological damage.

How the diagnosis is made

From first symptoms to a confirmed cause.

The steps a UK neurologist and oncologist will normally follow together, in order - so you know what to expect and why.

  1. 01

    Assessing

    Detailed neurological history

    A careful account of how symptoms started and evolved - onset over days to weeks is typical and helps distinguish this from other conditions.

  2. 02

    Assessing

    Full neurological examination

    Checking coordination, memory, muscle strength and reflexes to map which part of the nervous system is affected.

  3. 03

    Confirming

    Onconeural antibody testing

    Blood and sometimes CSF sent for anti-Hu, anti-Yo, anti-Ri and other antibodies specific to the suspected syndrome.

  4. 04

    Confirming

    MRI brain and spine

    Looks for characteristic inflammatory changes - for example in the limbic system in encephalitis - and rules out other structural causes.

  5. 05

    Confirming

    Lumbar puncture (CSF analysis)

    Checks for inflammation, oligoclonal bands and antibodies in the cerebrospinal fluid when a neurological syndrome is suspected.

  6. 06

    Finding the cancer

    Whole-body cancer screening

    CT chest, abdomen and pelvis, tumour markers and often a PET-CT - because the underlying cancer may not yet be apparent on standard imaging.

  7. 07

    Finding the cancer

    Joint neurology-oncology care

    A specialist multidisciplinary team plans treatment of the cancer alongside immunomodulation, with regular review of residual symptoms.

Typical timeline: weeks from first specialist review to a confirmed diagnosis and treatment plan.

Symptoms

What paraneoplastic syndromes actually look like.

Presentation varies enormously by syndrome and by which part of the nervous system - or which other organ system - is affected.

  • Progressive ataxia

    Unsteady walking, poor coordination and slurred speech - the hallmark of paraneoplastic cerebellar degeneration.

  • Memory and mood changes

    New confusion, memory loss, seizures or personality change point towards limbic encephalitis.

  • Fluctuating muscle weakness

    Proximal weakness that improves with repeated effort suggests Lambert-Eaton myasthenic syndrome, unlike myasthenia gravis.

  • Unusual eye and limb jerks

    Rapid, chaotic eye movements with myoclonic jerks characterise opsoclonus-myoclonus syndrome.

  • Tingling and numbness

    Peripheral neuropathy causing pins and needles, numbness or burning pain, often in the hands and feet.

  • Muscle weakness with a rash

    Dermatomyositis in adults - a violet rash over the eyelids and knuckles with proximal muscle weakness - carries a notable cancer association.

  • Thirst, confusion and constipation

    Hypercalcaemia from a PTHrP-secreting tumour can cause thirst, nausea, constipation and confusion.

  • Red flag - rapid neurological decline

    Fast-progressing neurological symptoms with no clear cause deserve urgent specialist assessment and cancer screening.

Treatment

How paraneoplastic syndromes are treated in the UK.

Treating the underlying cancer first, calming the autoimmune attack, and managing individual symptoms alongside rehabilitation.

  • Treating the underlying cancer

    The single most effective step for most paraneoplastic syndromes - surgery, chemotherapy or radiotherapy aimed at the tumour driving the immune response.

  • Intravenous immunoglobulin (IVIg)

    Dampens the autoimmune attack on nerves and muscle - commonly used for Lambert-Eaton syndrome and some neuropathies.

  • Plasma exchange

    Filters harmful antibodies from the blood - used in severe or rapidly progressive neurological presentations.

  • Corticosteroids

    High-dose steroids reduce inflammation quickly, often used alongside other immunotherapy in limbic encephalitis.

  • Rituximab

    A targeted antibody-depleting treatment used when first-line immunotherapy is not enough, particularly in antibody-mediated encephalitis.

  • 3,4-diaminopyridine

    A specific symptomatic treatment for Lambert-Eaton myasthenic syndrome that improves muscle strength and signal transmission.

  • Specialist neurology-oncology MDT

    Commissioned specialist teams coordinate cancer treatment with immunosuppression and rehabilitation for the best possible outcome.

  • Rehabilitation and symptom support

    Physiotherapy, occupational therapy and speech and language support manage residual disability once the immune attack is controlled.

What this guide is based on

The sources behind every claim on this page.

UK national guidance and specialist neurology society standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your neurologist or oncologist knows your case and history and can tell you which parts apply to you. If in doubt, get seen.

  • Association of British Neurologists. Guidance on paraneoplastic neurological syndromes.

  • NICE. Suspected cancer: recognition and referral (NG12).

  • Encephalitis Society. Autoimmune and paraneoplastic encephalitis patient information.

  • PNS Euronetwork. Diagnostic criteria for paraneoplastic neurological syndromes.

Red flags

When symptoms need urgent attention.

Most concerns can be worked up in a planned specialist pathway. These are the situations that can't wait.

  • Rapidly progressive ataxia

    Unsteadiness worsening over days to weeks, especially in someone over 50, needs urgent neurology assessment and cancer screening.

  • New seizures with confusion

    Seizures alongside memory loss or personality change may indicate limbic encephalitis and warrant same-day specialist review.

  • Breathing or swallowing difficulty

    Weakness affecting breathing or swallowing in suspected Lambert-Eaton syndrome is an emergency needing immediate hospital care.

  • Unexplained weight loss with neurological symptoms

    This combination should always prompt thorough cancer screening alongside the neurological work-up.

  • Severe hypercalcaemia

    Marked thirst, vomiting and confusion from high calcium levels can become life-threatening and needs urgent treatment.

  • SIADH and profound low sodium

    Seizures or reduced consciousness from severe hyponatraemia associated with small cell lung cancer require emergency correction.

  • New adult-onset dermatomyositis

    A new violet rash with proximal weakness in an adult should trigger prompt cancer screening, particularly in older patients.

  • Delayed diagnosis anxiety

    Waiting for antibody results or cancer screening is stressful - ask your team for a realistic timeline and who to contact with concerns.

  • Significant residual disability

    Even after cancer treatment, some neurological damage may not fully reverse - early, honest discussion helps with planning and support.

Living with it

A rare diagnosis, with a clear care pathway.

Four things that make the biggest difference day to day - patience with recovery, a joined-up team, active rehabilitation and steady follow-up.

A quiet reminder

You are not imagining your symptoms.

These syndromes are rare and can take time to name. Persisting with a specialist opinion, even after normal early tests, is often what gets to the answer.

  1. 01 Patience

    Recovery can be slow and partial

    Neurological damage may improve gradually over months, and some deficits can be permanent even with successful cancer treatment.

  2. 02 Team

    Keep both specialists involved

    Neurology and oncology teams should stay in close contact throughout - ask who is coordinating your care if this feels unclear.

  3. 03 Support

    Rehabilitation makes a difference

    Physiotherapy, occupational therapy and speech therapy meaningfully improve function and independence during recovery.

  4. 04 Follow-up

    Ongoing monitoring matters

    Regular review checks for cancer recurrence and tracks neurological progress, even once symptoms have settled.

Frequently asked

Everything we get asked about paraneoplastic syndromes.

Quick answers on the link to cancer, antibody testing, and what treatment actually involves.

  • What is a paraneoplastic syndrome?

    It is a disorder caused by the immune system reacting to a cancer somewhere in the body and, in the process, mistakenly attacking normal tissue - most often the nervous system, but sometimes muscles, skin or hormone levels. It is rare and distinct from the direct effects of a tumour spreading.

  • Can it appear before cancer is diagnosed?

    Yes, and this is one of the most important features. Symptoms can precede the discovery of the underlying cancer by months or even years, so recognising the pattern can prompt earlier cancer detection and treatment.

  • Which cancers are most often linked to these syndromes?

    Small cell lung cancer, ovarian cancer, thymoma, breast cancer and lymphoma are the most common triggers, though almost any cancer type can occasionally cause a paraneoplastic syndrome.

  • How is a paraneoplastic syndrome diagnosed?

    Through a combination of specific antibody blood tests, MRI brain or spine imaging, cerebrospinal fluid analysis where needed, and thorough whole-body cancer screening with CT and often PET-CT, since the tumour may not yet be visible.

  • What is the difference between Lambert-Eaton syndrome and myasthenia gravis?

    Both cause muscle weakness, but Lambert-Eaton weakness typically improves with repeated muscle use, while myasthenia gravis weakness worsens with use. Lambert-Eaton is more strongly associated with an underlying cancer, usually small cell lung cancer.

  • Will treating the cancer cure the syndrome?

    Treating the underlying cancer is the most effective step and often improves symptoms considerably, but neurological damage can be slow to recover and sometimes leaves lasting effects even after the cancer itself responds well to treatment.